Danaher Corp (DHR) 85.25 $DHR
Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 4:30PM CDT
CAM: 49.02 (+0.36), BBT: 38.87 (+0.21), LAZ: 56.56 (-0.08), JAH: 51.68 (-0.16), ASPS: 18.07 (+1.32), HSY: 98.33 (+0.31), CAB: 53.76 (-0.12), CFX: 48.68 (+0.12), FAF: 36.74 (+0.57), HP: 73.53 (+1.48), KKR: 23.37 (+0.21), AEP: 56.14 (+0.17), DNKN: 47.72 (+0.21), CLFD: 15.63 (+0.19), DAN: 21.57 (+0.18), ABBV: 64.52 (+0.91), CSL: 94.86 (+0.78), CAT: 84.87 (+0.95), BHE: 24.51 (-0.19), AVT: 45.49 (+0.28), IR: 67.49 (+0.29), COR: 48.82 (-0.57), ALK: 64.31 (-0.62), COL: 96.55 (+0.45), BKU: 33.64 (+0.12), BCC: 38.42 (-0.13), MJN: 98.92 (-1.00), IQNT: 18.03 (+0.28), ERIC: 12.70 (-0.09), DGX: 76.29 (+0.08), ALXN: 188.19 (+1.41), DOW: 50.02 (+0.37), DST: 116.35 (+0.44), MDP: 52.99 (-0.41), MMM: 164.67 (+0.67), GRA: 97.10 (+0.03), FCX: 20.57 (+0.34), CLI: 18.28 (-0.01), DHR: 85.25 (+0.05), FNB: 13.21 (+0.10), LUV: 42.85 (-0.18), DPS: 78.81 (-0.38), IVC: 19.80 (+0.24), GMT: 59.92 (+0.42), JNS: 17.93 (unch), DPZ: 99.80 (+0.40), DLX: 69.57 (+0.47), CMS: 35.07 (+0.15), LTM: 71.60 (+0.17), MDSO: 47.66 (+0.43), LLY: 72.30 (+0.09), BMS: 44.00 (+0.09), EQT: 87.29 (+0.85), MHO: 23.74 (-0.25), BTU: 4.87 (+0.06), GPK: 14.24 (+0.15), BAX: 70.38 (+0.33), EQM: 83.89 (+0.08), BEAV: 63.43 (-0.01), GM: 37.16 (unch), HUB.B: 110.19 (-0.19), JCI: 51.33 (+0.30)
Illumina: And The Beat Goes On
AtonRa Partners - at Seeking Alpha - Wed Apr 22, 10:47AM CDT
TMO: 130.69 (-3.75), ILMN: 190.04 (-9.27), DHR: 85.25 (+0.05)
Is Danaher (DHR) Poised to Beat Earnings This Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 21, 2:50PM CDT
Danaher Corp. (DHR) is scheduled to report first-quarter 2015 results before the opening bell on Apr 23.
AXS: 51.67 (-0.60), AMZN: 389.80 (-1.38), DHR: 85.25 (+0.05), AAPL: 128.62 (+1.71)
The Urinalysis Systems Market to Reach $1.28 Billion by 2019 - MarketsandMarkets
PRWeb - Sun Apr 19, 7:35PM CDT
The urinalysis market can be broadly divided into biochemical urinalysis and sediment urinalysis. The biochemical urinalysis market is highly fragmented due to presence of few big players and several small players. Prominent players in the biochemical urinalysis market include Siemens Healthcare (Germany), Roche Diagnostics (Switzerland) and Danaher Corporation (U.S.) while the key players in the sediment urinalysis market include Danaher Corporation (U.S.), Sysmex Corporation (Japan) and Urit Medical (China).
DHR: 85.25 (+0.05)
Look for Shares of Danaher to Potentially Rebound after Yesterday's 1.43% Sell Off
Comtex SmarTrend(R) - Fri Apr 17, 4:24PM CDT
Danaher (NYSE
HR) traded in a range yesterday that spanned from a low of $83.74 to a high of $84.80. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $84.61 on volume of 3.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
DHR: 85.25 (+0.05)
After Yesterday's Decline of 1.43%, Danaher Offers Investors Better Value
Comtex SmarTrend(R) - Fri Apr 17, 4:23PM CDT
Danaher (NYSE HR) traded in a range yesterday that spanned from a low of $83.74 to a high of $84.80. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $84.61 on volume of 3.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
DHR: 85.25 (+0.05)
Global Life Science and Chemical Instrumentation Market Report 2015-2019
M2 - Wed Apr 15, 3:52AM CDT
Research and Markets (http://www.researchandmarkets.com/research/q5vdnx/life_science_and) has announced the addition of the "Life Science and Chemical Instrumentation Market (Chromatography, Electrophoresis, DNA Sequencer, PCR, Microplate Reader, Robotics, Spectroscopy, Immunoassay, Microarray, Flow Cytometer, Incubator, Fume Hood, Centrifuge) - Global Forecast to 2019" report to their offering. The global life science and chemical instrumentation market is estimated to grow at a CAGR of 6.9% from 2014 to 2019 Although mature markets (such as the U.S., Germany, France, and the U.K.) held larger shares in the global life science and chemical instrumentation market in 2014, the Asia-Pacific region is poised to grow at the highest rate in the next five years. Factors such as strategic expansion by key market players in emerging Asian countries; growing pharmaceutical and biopharmaceutical industry; rising government investments in biomedical industry in China and Singapore, and extensive crop research in Asia to feed its increasing population are propelling the demand of the life science and chemical instrumentations in Asia-Pacific region. The growth of the global life science and chemical instrumentation market is driven by factors such as rising pharmaceutical R&D investments in emerging countries, increasing food safety concerns, availability of public and private funding for life science research studies, advancements in analytical instruments in terms of technology, miniaturization of instruments, and stringent drug development regulations in developed countries. In addition, emerging economies and increasing demand of analytical instruments from applied markets are creating new growth opportunities for the life science and chemical instrumentation manufacturers. Nonetheless, the high cost of technologically advanced instruments, scarcity of skilled professionals, and presence of alternative analytical technologies are the key reasons hampering the growth of life science and chemical instrumentation market. Geographically, North America (comprising the U.S. and Canada) commanded the largest share of the global life science and chemical instrumentation market in 2014, followed by Europe. The North American life science and chemical instrumentation market is driven by factors such as stringent drug development regulations, public and private funding for life science research activities, growing number of metabolomics research studies, rising prevalence of chronic diseases and aging population (that is responsible for the boost in the research on bio-based drugs), and a significant number of conferences, discussions, symposium, & seminars hosted by North America related to analytical technologies. However, increasing outsourcing of clinical research by big U.S. pharma companies to developing Asian countries and changes in the Canadian R&D tax credit program are negatively affecting the growth of the life science and chemical instrumentation market in North America. New product launches, partnerships, agreements, collaborations, and geographic expansions were the major strategies adopted by most of the market players to achieve growth in the life science and chemical instrumentation market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Life Science and Chemical Instrumentation Market, By Technology 8 Life Science and Chemical Instrumentation Market, By End User 9 Geographic Analysis 10 Competitive Landscape 11 Company Profiles - Agilent Technologies, Inc. - Becton, Dickinson and Company - Bio-Rad Laboratories, Inc. - Bruker Corporation - Danaher Corporation - F. Hoffmann-LA Roche Ltd. - Perkinelmer, Inc. - Shimadzu Corporation - Thermo Fisher Scientific, Inc. - Waters Corporation For more information visit http://www.researchandmarkets.com/research/q5...cience_and
A: 42.71 (-0.18), DHR: 85.25 (+0.05), WAT: 124.08 (-0.08)
Global Water Testing & Analysis Market 2015-2019 with Danaher, General Electric, ABB & Thermo Fisher Scientific Dominating the $3.5 Billion Market
PR Newswire Europe - Mon Apr 13, 1:00PM CDT
DUBLIN, April 13, 2015 /PRNewswire/ --
DHR: 85.25 (+0.05)
Industrials Sector Stocks Technical Review -- General Electric, 3M, Danaher, Jacobs Engineering, and Koninklijke Philips N.V.
PR Newswire - Mon Apr 13, 7:55AM CDT
Editor Note: For more information about this release, please scroll to bottom.
MMM: 164.67 (+0.67), JEC: 46.95 (-0.17), GE: 26.91 (+0.29), PHG: 29.36 (-0.09), DHR: 85.25 (+0.05)
Water Testing & Analysis Market - Global Trends & Forecast to 2019
M2 - Mon Apr 13, 6:41AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bt5v3m/water_testing_and) has announced the addition of the "Water Testing & Analysis Market by Product, Product Type, Application & Region - Global Trends & Forecast to 2019" report to their offering. The market for global water testing and analysis instruments is projected to grow at a CAGR of 5.2% to reach a value of $3.5 billion by 2019. The market for water testing & analysis is observed to be growing at a modest rate in developed economies such as Europe and North America as compared to developing regions due to the matured industrial & laboratory application sectors in the former. Laboratories are still major consumers of water testing & analysis and this application segment is expected to grow at a healthy rate. Increasing government regulations for water quality and rising environmental issues of water contamination and pollution increase the demand for water testing & analysis instruments are driving the market. The Asia-Pacific region is projected to be the fastest-growing market for water testing & analysis, at a CAGR of 7.0% from 2014 to 2019. The industrial sector usage of water testing & analysis is comparatively higher in this region as compared to developed regions, which presents the water testing & analysis manufacturers and suppliers with immense untapped potential. Rapid urbanization & industrialization coupled with increasing stress on water quality in the developing Asia-Pacific regions are the key growth drivers for this region. The market is dominated by many large companies and comprises various regional large and medium-scale players. The key players identified in the spice industry are Danaher Corporation (U.S.), General Electric (U.S.), ABB Ltd. (U.S.), and Thermo Fisher Scientific (U.S.). Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 4.7 Water Testing & Analysis Market: Life Cycle Analysis, By Region 5 Market Overview 6 Industry Trends 7 Water Testing & Analysis Market, By Product 8 Water Testing & Analysis Market, By Product Type 9 Water Testing & Analysis Market, By Application 10 Water Testing & Analysis Market, By Region 11 Competitive Landscape 12 Company Profiles - Abb Ltd. - Agilent Technologies Inc. - Danaher Corporation - Danaher Corporation - Emerson Electric Co. - General Electric Company - Honeywell International Inc. - Horiba, Ltd. - Mettler-Toledo International Inc. - Shimadzu Corporation - Thermo Fisher Scientific, Inc. - Tintometer Gmbh For more information visit http://www.researchandmarkets.com/research/bt...esting_and
GE: 26.91 (+0.29), ABB: 21.85 (-0.22), HON: 102.19 (+0.86), A: 42.71 (-0.18), EMR: 58.15 (-0.07), DHR: 85.25 (+0.05), MTD: 324.14 (+0.66)
Roper's Acquisitions to Drive Growth, Debt Remains a Drag - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 10, 2:00PM CDT
We have issued an updated research report on Roper Industries, Inc. (ROP) on Apr 9, 2015.
ROP: 168.93 (+0.69), IR: 67.49 (+0.29), DOV: 71.89 (-0.04), DHR: 85.25 (+0.05)
United States Blood Transfusion Diagnostics Market - Forecasts Begin in 2015 and End in 2018 with a Base Year of 2014
M2 - Thu Apr 09, 3:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7q7mtv/the_us_blood) has announced the addition of the "The US Blood Transfusion Diagnostics Market " report to their offering. This research study focuses on diagnostic tests performed on blood donor samples. The market segments are divided by blood grouping and disease screening and cover manual and automated instruments as well as reagents used for Abo and Rh testing, RBC antigen, and antibody identification and detection. Disease screening includes both serological and molecular testing. Comprehensive reports on test volume and pricing analysis for donor serological tests, blood grouping, and molecular tests are provided. The market forecasts begin in 2015 and end in 2018 using a base year of 2014. Supplier market shares, extensive product analysis, and new market opportunities to tackle the decreasing demand for blood supply are discussed. The majority of the quantitative and qualitative information contained in this research service was acquired through primary research conducted with blood banking product providers. Most consultations were conducted with vice presidents (VPs) of business units, VPs of marketing, product managers, marketing managers, marketing directors, and business development directors from various competitors in the liquid handling market. Key Topics Covered: 1. Executive Summary - Key Findings - Scope and Segmentation - Market Segmentation - Key Questions This Study Will Answer - Market Engineering Measurements - CEO's Perspective - Key Companies to Watch 2. Market Overview - Market Background - Market Background-Types of Blood Bank Analyzers - Comparison of Immunohematology Methods - Voice of Customer-Factors Governing Equipment Purchase for a Transfusion Laboratory - Voice of Customer - Market Segmentation - Procurement Process - Defining Future Healthcare Trends 3. Competitive Playbook - New Market Opportunities 4. Drivers, Restraints, and Trends-Total Blood Transfusion Diagnostics Market - Market Drivers - Market Restraints - Market Impact of Top 6 Trends 5. Forecasts and Trends-Total Blood Transfusion Diagnostics Market - Market Engineering Measurements - Factors Impacting Market Forecasts - Revenue Forecast - Revenue Forecast Discussion 6. Blood Grouping Segment Analysis - Revenue Forecast - Revenue Forecast Discussion - Test Volume for Abo, Rh, RBC Antigen Typing, Antibody Identification, and Screening - Medicare Expenditure for Abo, Rh, and RBC Antigen Typing - Test Volume and Pricing Analysis for Blood Grouping Tests - Medicare Expenditure for Antibody Screening, Identification, and Cross Matching 7. Disease Screening Segment Analysis - Revenue Forecast - Revenue Forecast for Serological and Molecular - Revenue Forecast Discussion - Revenue Forecast Discussion (continued) - Test Volume and Pricing Analysis for Disease Screening and NAT Tests - Test Volume Serological Donor Screening Tests - Cost Comparison per Test for Serological and NAT - Most Frequently Ordered Blood Tests by Rank 8. Accredited Transfusion Centers - Accredited Immunohematology Reference Laboratories - Blood Transfusion Centers 9. Overview of Blood Bank Supply Chain - Overview of Supply Chain in Blood Banks - Problem Areas and Solution 10. Competitive Environment - Market Share - Market Share Analysis - Product Analysis Blood Grouping - Product Analysis Disease Screening (Serological and Molecular) - Product Analysis Disease Screening (Molecular Assays) - Merger, Acquisition, and Partnership Assessment 11. Company Profiles - Immucor - Ortho Clinical Diagnostics - Beckman Coulter (Danaher) - BioRad 12. Key Companies to Watch - Quotient Limited (previously known as Alba Bioscience) - Immucor - Diagast - 3Ti (Transfusion & Transplantation Technologies) 13. The Last Word 14. Appendix For more information visit http://www.researchandmarkets.com/research/7q...e_us_blood
DHR: 85.25 (+0.05)
6 Takeover Target Stocks in the Industrials Sector
Lee Samaha, The Motley Fool - Motley Fool - Wed Apr 08, 10:32AM CDT
In a previous article I looked at the recent history of mergers and acquisitions in the industrials sector and concluded that future deals were likely to involve companies making horizontal and/or vertical acquisitions within their core business...
UTX: 116.96 (+0.01), DHR: 85.25 (+0.05), CHMT: 30.13 (+0.13)
NetScout, Danaher Postpone Deal's Closing Date to Give Regulators More Time
at The Street - Wed Apr 08, 8:51AM CDT
NetScout is buying Tektronix, Fluke Networks and Arbor Networks from Danaher, and the Justice Department has issued a second request for information regarding the transaction.
NTCT: 44.88 (+0.44), JDSU: 13.36 (+0.01), DHR: 85.25 (+0.05)
Protein Engineering Market 2015 - Technology, Product, Protein Type, End User Analysis - Global Forecasts to 2020
M2 - Wed Apr 08, 6:58AM CDT
Research and Markets (http://www.researchandmarkets.com/research/shqb75/protein) has announced the addition of the "Protein Engineering Market by Technology (Rational Protein Design, Irrational Protein Design), Product (Instrument, Services), Protein Type (Monoclonal Antibodies, Interferon, Growth Hormone), End User (Academics Institutes, CROs) - Global Forecast to 2020" report to their offering. The protein engineering market is expected to grow at a double-digit CAGR of 15.7% to reach $1,463.0 million by 2020 from $705.5 million in 2015 Major factors fueling market growth are the increase in adoption of protein drugs over non-protein drugs, high prevalence rate of lifestyle diseases, growth in funding for protein engineering, and reduction in overall timeline and cost for drug discovery. However, expensive and high maintenance tools and instruments used in protein engineering and dearth of trained personnel are restricting the growth of the market. This market is broadly segmented into instrument, reagent and services and software, by product. On the basis of technology the market is segmented into rational protein design, and irrational protein design. Rational protein design emerged as highly adopted technology in protein engineering market in 2014. Based on protein type, the market is categorized into monoclonal antibodies, insulin, erythropoietin, interferon, colony stimulating factor, growth hormones, coagulation factor, vaccines and others (interleukins, follicle stimulating hormones, enzyme replacement). Monoclonal antibodies is the largest as well as fastest growing segment of the protein engineering protein type market. Based on end user, the protein engineering market is broadly classified into academic research institutes, pharmaceutical and biotechnology companies and contract research organizations. Pharmaceutical and biotechnology companies is the largest and fastest-growing end user segment. The high growth rate of this market can be attributed to technological advancements in protein engineering and the increase in R&D budgets in the pharmaceutical sector. Geographically, this market is dominated by North America, followed by Europe. Asia is expected to be the fastest growing region during the forecast period. Key players operating in this market are AB-Sciex (U.S.), Agilent Technologies (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corp. (U.S.), , GE Healthcare (U.K.), Perkin Elmer (U.S.), Sigma-Aldrich Corp. (U.S.), Thermo Fisher Scientific (U.S.), and Waters Corp. (U.S). Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Protein Engineering Market, By Product 8 Protein Engineering Market, By Technology 9 Protein Engineering Market, By Protein Type 10 Protein Engineering Market, By End User 11 Geographic Analysis 12 Competitive Landscape 13 Company Profiles - Agilent Technologies, Inc - Bio-Rad Laboratories, Inc - Bruker Corporation - Danaher Corporation - General Electric - Genscripts Usa, Inc. - Perkinelmer, Inc - Sigma-Aldrich Corporation - Thermo Fisher Scientific - Waters Corporation For more information visit http://www.researchandmarkets.com/research/shqb75/protein
A: 42.71 (-0.18), SIAL: 138.92 (+0.17), DHR: 85.25 (+0.05), WAT: 124.08 (-0.08)
Global Cell Analysis Market Report 2015 - Forecast to 2020
M2 - Wed Apr 08, 6:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/v8px4d/cell_analysis) has announced the addition of the "Cell Analysis Global Market - Forecast To 2020" report to their offering. Cell analysis plays a major role in gene identification, protein identification, transcription analysis and epigenomics at cellular level. It proves to be an ultra-sensitive device to elucidate specific molecular processes and pathways and reveal the nature of cell heterogenecity. Hospitals, academic institutions, government bodies, as well as pharmaceutical and biotechnology firms are increasing their focus on application of cell analysis as a modern emerging tool in research, drug discovery and diagnosis. The cell analysis techniques global market is segmented into molecular approaches, image-based approaches and others. The molecular approaches include the PCR, NGS and Microfluidics, cell isolation & separation techniques performed at cells genomic level, where as the image-based approaches include microscopes, FISH, FRAP, tracking, high content screening (HCS), cytometry techniques etc. The cell analysis products market is mainly segmented into consumables and instruments. The consumables include reagents, assay plates and microplates where as the instrument segment comprises of microscopes, flow cytometers, spectrophotometer, quantitative polymerase chain reaction (QPCR), microfluidic devices, cell counters, high content screening (HCS) systems and cell microarrays. By application, the market is segmented into by processes, by feild and by therapeutics. By processes is segmented into Cellular processes, Signal transduction pathways, Circulating tumor cells, Single cell analysis, Epigentic target analysis, Subpopulation Characterization, Drug and candidate screening. By field is further segmented into forensic Science, therapeutics, cell imaging, biomarker research, genomic analysis, stem cell analysis, and diagnostics. By therapeutics is further segmented into cancer research, infectious disease diagnosis, genetic testing, immunology, others. By end-users, the market is segmented into Hospitals, Academic and Research Institutes, Contract Research Organizations (CROs), Pharmaceuticals and Biotechnology Companies, Cell Banks, Diagnostic Laboratories and others. By geography, the market is segmented into North America, Europe, Asia Pacific and Rest of World. North America holds the largest market share, followed by Europe and Asia. The APAC regions tend to be an emerging market with an opportunity for growth and are likely to be a destination of investment for new investors in the cell analysis market. Drug discovery services outsourcing and government funding for novel screening technologies has resulted in growth of Asian markets. The cell analysis market is expected to grow at a rate of 9.6% during the forecast period. The major factor influencing the growth is enhanced precision of cell imaging and analysis systems which in turn reduce time and cost of drug discovery process. In addition, the factors like increasing incidence of cancer, increasing government investments, funds and grants, availability of reagents and cell analysis instruments are driving the growth of the market. However, the major market restraints include high capital investments and shortage of skilled labour for high content screening procedure. The biggest opportunities for this market is the emerging APAC market, high content screening services provided by contract research organizations, automation in cancer research for its early diagnosis and reduction of cost in the cancer treatment. Key Topics Covered: 1 Executive Summary 2 Introduction 3 Market Analysis 4 Cell Analysis Global Market, Techniques 5 Global Cell Analysis Products Market 6 Global Cell Analysis Applications Market 7 Cell Analysis Global Market, By End-Users 8 Regional Market Analysis 9 Company Developments 10 Major Player Profiles - Agilent Technologies, Inc. - Beckton, Dickinson And Company - Danaher Corporation - GE Healthcare - Merck KGaA - Olympus Corpopration - Perkinelmer, Inc - Promega Corporation - Sigma-Aldrich Corporation - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/v8...l_analysis
A: 42.71 (-0.18), SIAL: 138.92 (+0.17), DHR: 85.25 (+0.05)
Electric Motors - Global Strategic Business Report 2015-2020: Growth in Automotive Production Bodes Well for the Market
M2 - Tue Mar 31, 6:04AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jndtng/electric_motors) has announced the addition of the "Electric Motors - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Electric Motors in US$ Million by the following Segments: Fractional HP, and Integral HP. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 466 companies including many key and niche players such as: - ABB Ltd. (Switzerland) - Baldor Electric Company (USA) - ACTOM (Pty) Ltd (South Africa) - Allied Motion Technologies, Inc. (USA) - Ametek Inc. (USA) - ARC Systems Inc. (USA) - Asmo Co., Ltd (Japan) - Bauer Gear Motor (Germany) - Brook Crompton (UK) - Crompton Greaves Ltd. (India) - Danaher Motion (USA) - Franklin Electric Co. Inc., (USA) - General Electric Company (USA) - Hitachi, Ltd. (Japan) - Hyosung Corporation (South Korea) - Johnson Electric Holdings Ltd. (Hong Kong) - Kirloskar Electric Company Ltd. (India) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. MARKET DYNAMICS, TRENDS & ISSUES 3. PRODUCT OVERVIEW 4. PRODUCT INNOVATIONS/INTRODUCTIONS 5. RECENT INDUSTRY ACTIVITY 6. FOCUS ON SELECT KEY PLAYERS 7. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 466 (including Divisions/Subsidiaries - 520) - The United States (98) - Canada (2) - Japan (24) - Europe (241) - - France (11) - - Germany (58) - - The United Kingdom (26) - - Italy (67) - - Spain (
- - Rest of Europe (71) - Asia-Pacific (Excluding Japan) (143) - Latin America (1) - Middle East (6) - Africa (5) For more information visit http://www.researchandmarkets.com/research/jn...ric_motors
GE: 26.91 (+0.29), ABB: 21.85 (-0.22), AME: 52.35 (+0.28), FELE: 38.87 (+0.14), AMOT: 40.48 (+1.00), DHR: 85.25 (+0.05)
Global Blood Screening Market to 2019: Nucleic Acid Amplification Test, ELISA, Rapid Test, Chemiluminescence Immunoassay, Next Generation Sequencing, Western Blotting
M2 - Mon Mar 30, 7:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jbkxl3/blood_screening) has announced the addition of the "Blood Screening Market by Technology (Nucleic Acid Amplification Test, ELISA, Rapid Test, Chemiluminescence Immunoassay, Next Generation Sequencing, Western Blotting), Product (Instrument, Reagent) & End User (Blood Bank, Hospital) - Forecasts to 2019 " report to their offering. The blood screening market is expected to reach $2.55 billion by 2019 from $1.5 billion in 2014, growing at a CAGR of 10.4% from 2014 to 2019. The global market is segmented on the basis of products and services, technologies, end users, and regions. The blood screening market is a growing field that has witnessed a number of technological advancements since its inception, such as a shift from first-generation ELISA to advanced NAT technologies. This market is driven by several factors including increasing number of blood donations and blood donors, rising awareness regarding the safety of donated blood, increasing patient affordability, increasing adoption of NAT, and rising demand of donated blood. However, factors such as high capital expenditure and operating cost of NAT and stringent regulatory approval processes are likely to hinder the growth of this market. The blood screening market in Asia is likely to provide an array of opportunities owing to the growing demand for donated blood, increasing disposable income (leading to adoption of NAT ), and increased focus of key players in the Asian region. On the basis of products and services, the global market is segmented into instruments (hardware), reagents, and software and services. The blood screening instruments market is further segmented into rental purchase and outright purchase; while the blood screening reagents market segment is classified into ELISA reagents, NAT reagents, and other reagents. On the basis of technologies, the global global market is segmented into nucleic acid tests (NAT), enzyme-linked immunosorbent assays (ELISA), enzyme immunoassays (EIAs) and chemiluminescent immunoassays (CLIAs), next-generation sequencing (NGS), and Western blot assays. The blood screening NAT market is further segmented into transcription mediated amplification (TMA) and real-time PCR. The blood screening market for ELISA testing is further categorized into card methodology, first-generation, second-generation, third-generation, and fourth-generation ELISA. Based on end users, the blood screening market is segmented into blood banks and hospitals. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Blood Screening Market, By Technology 8 Blood Screening Market, By Products and Services 9 Blood Screening Market, By End User 10 Blood Screening Market, By Region 11 Competitive Landscape 12 Company Profiles - Abbott Laboratories - Beckman Coulter (Subsidiary of Danaher Corporation) - Becton, Dickinson and Company - Bio-Rad Laboratories, Inc. - Biom?rieux - Grifols - Ortho-Clinical Diagnostics, Inc. - Roche Diagnostics (A Division of F. Hoffmann-La Roche Ltd) - Siemens Healthcare (Subsidiary of Siemens AG) - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/jb..._screening
ABT: 48.35 (+1.23), DHR: 85.25 (+0.05)
Danaher Schedules First Quarter 2015 Earnings Conference Call
PR Newswire - Thu Mar 26, 3:00PM CDT
Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the first quarter 2015 on Thursday, April 23, 2015 beginning at 8:00 a.m. ET and lasting approximately 1 hour.
DHR: 85.25 (+0.05)
Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 4:30PM CDT
CAM: 49.02 (+0.36), BBT: 38.87 (+0.21), LAZ: 56.56 (-0.08), JAH: 51.68 (-0.16), ASPS: 18.07 (+1.32), HSY: 98.33 (+0.31), CAB: 53.76 (-0.12), CFX: 48.68 (+0.12), FAF: 36.74 (+0.57), HP: 73.53 (+1.48), KKR: 23.37 (+0.21), AEP: 56.14 (+0.17), DNKN: 47.72 (+0.21), CLFD: 15.63 (+0.19), DAN: 21.57 (+0.18), ABBV: 64.52 (+0.91), CSL: 94.86 (+0.78), CAT: 84.87 (+0.95), BHE: 24.51 (-0.19), AVT: 45.49 (+0.28), IR: 67.49 (+0.29), COR: 48.82 (-0.57), ALK: 64.31 (-0.62), COL: 96.55 (+0.45), BKU: 33.64 (+0.12), BCC: 38.42 (-0.13), MJN: 98.92 (-1.00), IQNT: 18.03 (+0.28), ERIC: 12.70 (-0.09), DGX: 76.29 (+0.08), ALXN: 188.19 (+1.41), DOW: 50.02 (+0.37), DST: 116.35 (+0.44), MDP: 52.99 (-0.41), MMM: 164.67 (+0.67), GRA: 97.10 (+0.03), FCX: 20.57 (+0.34), CLI: 18.28 (-0.01), DHR: 85.25 (+0.05), FNB: 13.21 (+0.10), LUV: 42.85 (-0.18), DPS: 78.81 (-0.38), IVC: 19.80 (+0.24), GMT: 59.92 (+0.42), JNS: 17.93 (unch), DPZ: 99.80 (+0.40), DLX: 69.57 (+0.47), CMS: 35.07 (+0.15), LTM: 71.60 (+0.17), MDSO: 47.66 (+0.43), LLY: 72.30 (+0.09), BMS: 44.00 (+0.09), EQT: 87.29 (+0.85), MHO: 23.74 (-0.25), BTU: 4.87 (+0.06), GPK: 14.24 (+0.15), BAX: 70.38 (+0.33), EQM: 83.89 (+0.08), BEAV: 63.43 (-0.01), GM: 37.16 (unch), HUB.B: 110.19 (-0.19), JCI: 51.33 (+0.30)
Illumina: And The Beat Goes On
AtonRa Partners - at Seeking Alpha - Wed Apr 22, 10:47AM CDT
TMO: 130.69 (-3.75), ILMN: 190.04 (-9.27), DHR: 85.25 (+0.05)
Is Danaher (DHR) Poised to Beat Earnings This Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 21, 2:50PM CDT
Danaher Corp. (DHR) is scheduled to report first-quarter 2015 results before the opening bell on Apr 23.
AXS: 51.67 (-0.60), AMZN: 389.80 (-1.38), DHR: 85.25 (+0.05), AAPL: 128.62 (+1.71)
The Urinalysis Systems Market to Reach $1.28 Billion by 2019 - MarketsandMarkets
PRWeb - Sun Apr 19, 7:35PM CDT
The urinalysis market can be broadly divided into biochemical urinalysis and sediment urinalysis. The biochemical urinalysis market is highly fragmented due to presence of few big players and several small players. Prominent players in the biochemical urinalysis market include Siemens Healthcare (Germany), Roche Diagnostics (Switzerland) and Danaher Corporation (U.S.) while the key players in the sediment urinalysis market include Danaher Corporation (U.S.), Sysmex Corporation (Japan) and Urit Medical (China).
DHR: 85.25 (+0.05)
Look for Shares of Danaher to Potentially Rebound after Yesterday's 1.43% Sell Off
Comtex SmarTrend(R) - Fri Apr 17, 4:24PM CDT
Danaher (NYSE
HR) traded in a range yesterday that spanned from a low of $83.74 to a high of $84.80. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $84.61 on volume of 3.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion. DHR: 85.25 (+0.05)
After Yesterday's Decline of 1.43%, Danaher Offers Investors Better Value
Comtex SmarTrend(R) - Fri Apr 17, 4:23PM CDT
Danaher (NYSE
HR) traded in a range yesterday that spanned from a low of $83.74 to a high of $84.80. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $84.61 on volume of 3.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion. DHR: 85.25 (+0.05)
Global Life Science and Chemical Instrumentation Market Report 2015-2019
M2 - Wed Apr 15, 3:52AM CDT
Research and Markets (http://www.researchandmarkets.com/research/q5vdnx/life_science_and) has announced the addition of the "Life Science and Chemical Instrumentation Market (Chromatography, Electrophoresis, DNA Sequencer, PCR, Microplate Reader, Robotics, Spectroscopy, Immunoassay, Microarray, Flow Cytometer, Incubator, Fume Hood, Centrifuge) - Global Forecast to 2019" report to their offering. The global life science and chemical instrumentation market is estimated to grow at a CAGR of 6.9% from 2014 to 2019 Although mature markets (such as the U.S., Germany, France, and the U.K.) held larger shares in the global life science and chemical instrumentation market in 2014, the Asia-Pacific region is poised to grow at the highest rate in the next five years. Factors such as strategic expansion by key market players in emerging Asian countries; growing pharmaceutical and biopharmaceutical industry; rising government investments in biomedical industry in China and Singapore, and extensive crop research in Asia to feed its increasing population are propelling the demand of the life science and chemical instrumentations in Asia-Pacific region. The growth of the global life science and chemical instrumentation market is driven by factors such as rising pharmaceutical R&D investments in emerging countries, increasing food safety concerns, availability of public and private funding for life science research studies, advancements in analytical instruments in terms of technology, miniaturization of instruments, and stringent drug development regulations in developed countries. In addition, emerging economies and increasing demand of analytical instruments from applied markets are creating new growth opportunities for the life science and chemical instrumentation manufacturers. Nonetheless, the high cost of technologically advanced instruments, scarcity of skilled professionals, and presence of alternative analytical technologies are the key reasons hampering the growth of life science and chemical instrumentation market. Geographically, North America (comprising the U.S. and Canada) commanded the largest share of the global life science and chemical instrumentation market in 2014, followed by Europe. The North American life science and chemical instrumentation market is driven by factors such as stringent drug development regulations, public and private funding for life science research activities, growing number of metabolomics research studies, rising prevalence of chronic diseases and aging population (that is responsible for the boost in the research on bio-based drugs), and a significant number of conferences, discussions, symposium, & seminars hosted by North America related to analytical technologies. However, increasing outsourcing of clinical research by big U.S. pharma companies to developing Asian countries and changes in the Canadian R&D tax credit program are negatively affecting the growth of the life science and chemical instrumentation market in North America. New product launches, partnerships, agreements, collaborations, and geographic expansions were the major strategies adopted by most of the market players to achieve growth in the life science and chemical instrumentation market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Life Science and Chemical Instrumentation Market, By Technology 8 Life Science and Chemical Instrumentation Market, By End User 9 Geographic Analysis 10 Competitive Landscape 11 Company Profiles - Agilent Technologies, Inc. - Becton, Dickinson and Company - Bio-Rad Laboratories, Inc. - Bruker Corporation - Danaher Corporation - F. Hoffmann-LA Roche Ltd. - Perkinelmer, Inc. - Shimadzu Corporation - Thermo Fisher Scientific, Inc. - Waters Corporation For more information visit http://www.researchandmarkets.com/research/q5...cience_and
A: 42.71 (-0.18), DHR: 85.25 (+0.05), WAT: 124.08 (-0.08)
Global Water Testing & Analysis Market 2015-2019 with Danaher, General Electric, ABB & Thermo Fisher Scientific Dominating the $3.5 Billion Market
PR Newswire Europe - Mon Apr 13, 1:00PM CDT
DUBLIN, April 13, 2015 /PRNewswire/ --
DHR: 85.25 (+0.05)
Industrials Sector Stocks Technical Review -- General Electric, 3M, Danaher, Jacobs Engineering, and Koninklijke Philips N.V.
PR Newswire - Mon Apr 13, 7:55AM CDT
Editor Note: For more information about this release, please scroll to bottom.
MMM: 164.67 (+0.67), JEC: 46.95 (-0.17), GE: 26.91 (+0.29), PHG: 29.36 (-0.09), DHR: 85.25 (+0.05)
Water Testing & Analysis Market - Global Trends & Forecast to 2019
M2 - Mon Apr 13, 6:41AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bt5v3m/water_testing_and) has announced the addition of the "Water Testing & Analysis Market by Product, Product Type, Application & Region - Global Trends & Forecast to 2019" report to their offering. The market for global water testing and analysis instruments is projected to grow at a CAGR of 5.2% to reach a value of $3.5 billion by 2019. The market for water testing & analysis is observed to be growing at a modest rate in developed economies such as Europe and North America as compared to developing regions due to the matured industrial & laboratory application sectors in the former. Laboratories are still major consumers of water testing & analysis and this application segment is expected to grow at a healthy rate. Increasing government regulations for water quality and rising environmental issues of water contamination and pollution increase the demand for water testing & analysis instruments are driving the market. The Asia-Pacific region is projected to be the fastest-growing market for water testing & analysis, at a CAGR of 7.0% from 2014 to 2019. The industrial sector usage of water testing & analysis is comparatively higher in this region as compared to developed regions, which presents the water testing & analysis manufacturers and suppliers with immense untapped potential. Rapid urbanization & industrialization coupled with increasing stress on water quality in the developing Asia-Pacific regions are the key growth drivers for this region. The market is dominated by many large companies and comprises various regional large and medium-scale players. The key players identified in the spice industry are Danaher Corporation (U.S.), General Electric (U.S.), ABB Ltd. (U.S.), and Thermo Fisher Scientific (U.S.). Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 4.7 Water Testing & Analysis Market: Life Cycle Analysis, By Region 5 Market Overview 6 Industry Trends 7 Water Testing & Analysis Market, By Product 8 Water Testing & Analysis Market, By Product Type 9 Water Testing & Analysis Market, By Application 10 Water Testing & Analysis Market, By Region 11 Competitive Landscape 12 Company Profiles - Abb Ltd. - Agilent Technologies Inc. - Danaher Corporation - Danaher Corporation - Emerson Electric Co. - General Electric Company - Honeywell International Inc. - Horiba, Ltd. - Mettler-Toledo International Inc. - Shimadzu Corporation - Thermo Fisher Scientific, Inc. - Tintometer Gmbh For more information visit http://www.researchandmarkets.com/research/bt...esting_and
GE: 26.91 (+0.29), ABB: 21.85 (-0.22), HON: 102.19 (+0.86), A: 42.71 (-0.18), EMR: 58.15 (-0.07), DHR: 85.25 (+0.05), MTD: 324.14 (+0.66)
Roper's Acquisitions to Drive Growth, Debt Remains a Drag - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 10, 2:00PM CDT
We have issued an updated research report on Roper Industries, Inc. (ROP) on Apr 9, 2015.
ROP: 168.93 (+0.69), IR: 67.49 (+0.29), DOV: 71.89 (-0.04), DHR: 85.25 (+0.05)
United States Blood Transfusion Diagnostics Market - Forecasts Begin in 2015 and End in 2018 with a Base Year of 2014
M2 - Thu Apr 09, 3:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7q7mtv/the_us_blood) has announced the addition of the "The US Blood Transfusion Diagnostics Market " report to their offering. This research study focuses on diagnostic tests performed on blood donor samples. The market segments are divided by blood grouping and disease screening and cover manual and automated instruments as well as reagents used for Abo and Rh testing, RBC antigen, and antibody identification and detection. Disease screening includes both serological and molecular testing. Comprehensive reports on test volume and pricing analysis for donor serological tests, blood grouping, and molecular tests are provided. The market forecasts begin in 2015 and end in 2018 using a base year of 2014. Supplier market shares, extensive product analysis, and new market opportunities to tackle the decreasing demand for blood supply are discussed. The majority of the quantitative and qualitative information contained in this research service was acquired through primary research conducted with blood banking product providers. Most consultations were conducted with vice presidents (VPs) of business units, VPs of marketing, product managers, marketing managers, marketing directors, and business development directors from various competitors in the liquid handling market. Key Topics Covered: 1. Executive Summary - Key Findings - Scope and Segmentation - Market Segmentation - Key Questions This Study Will Answer - Market Engineering Measurements - CEO's Perspective - Key Companies to Watch 2. Market Overview - Market Background - Market Background-Types of Blood Bank Analyzers - Comparison of Immunohematology Methods - Voice of Customer-Factors Governing Equipment Purchase for a Transfusion Laboratory - Voice of Customer - Market Segmentation - Procurement Process - Defining Future Healthcare Trends 3. Competitive Playbook - New Market Opportunities 4. Drivers, Restraints, and Trends-Total Blood Transfusion Diagnostics Market - Market Drivers - Market Restraints - Market Impact of Top 6 Trends 5. Forecasts and Trends-Total Blood Transfusion Diagnostics Market - Market Engineering Measurements - Factors Impacting Market Forecasts - Revenue Forecast - Revenue Forecast Discussion 6. Blood Grouping Segment Analysis - Revenue Forecast - Revenue Forecast Discussion - Test Volume for Abo, Rh, RBC Antigen Typing, Antibody Identification, and Screening - Medicare Expenditure for Abo, Rh, and RBC Antigen Typing - Test Volume and Pricing Analysis for Blood Grouping Tests - Medicare Expenditure for Antibody Screening, Identification, and Cross Matching 7. Disease Screening Segment Analysis - Revenue Forecast - Revenue Forecast for Serological and Molecular - Revenue Forecast Discussion - Revenue Forecast Discussion (continued) - Test Volume and Pricing Analysis for Disease Screening and NAT Tests - Test Volume Serological Donor Screening Tests - Cost Comparison per Test for Serological and NAT - Most Frequently Ordered Blood Tests by Rank 8. Accredited Transfusion Centers - Accredited Immunohematology Reference Laboratories - Blood Transfusion Centers 9. Overview of Blood Bank Supply Chain - Overview of Supply Chain in Blood Banks - Problem Areas and Solution 10. Competitive Environment - Market Share - Market Share Analysis - Product Analysis Blood Grouping - Product Analysis Disease Screening (Serological and Molecular) - Product Analysis Disease Screening (Molecular Assays) - Merger, Acquisition, and Partnership Assessment 11. Company Profiles - Immucor - Ortho Clinical Diagnostics - Beckman Coulter (Danaher) - BioRad 12. Key Companies to Watch - Quotient Limited (previously known as Alba Bioscience) - Immucor - Diagast - 3Ti (Transfusion & Transplantation Technologies) 13. The Last Word 14. Appendix For more information visit http://www.researchandmarkets.com/research/7q...e_us_blood
DHR: 85.25 (+0.05)
6 Takeover Target Stocks in the Industrials Sector
Lee Samaha, The Motley Fool - Motley Fool - Wed Apr 08, 10:32AM CDT
In a previous article I looked at the recent history of mergers and acquisitions in the industrials sector and concluded that future deals were likely to involve companies making horizontal and/or vertical acquisitions within their core business...
UTX: 116.96 (+0.01), DHR: 85.25 (+0.05), CHMT: 30.13 (+0.13)
NetScout, Danaher Postpone Deal's Closing Date to Give Regulators More Time
at The Street - Wed Apr 08, 8:51AM CDT
NetScout is buying Tektronix, Fluke Networks and Arbor Networks from Danaher, and the Justice Department has issued a second request for information regarding the transaction.
NTCT: 44.88 (+0.44), JDSU: 13.36 (+0.01), DHR: 85.25 (+0.05)
Protein Engineering Market 2015 - Technology, Product, Protein Type, End User Analysis - Global Forecasts to 2020
M2 - Wed Apr 08, 6:58AM CDT
Research and Markets (http://www.researchandmarkets.com/research/shqb75/protein) has announced the addition of the "Protein Engineering Market by Technology (Rational Protein Design, Irrational Protein Design), Product (Instrument, Services), Protein Type (Monoclonal Antibodies, Interferon, Growth Hormone), End User (Academics Institutes, CROs) - Global Forecast to 2020" report to their offering. The protein engineering market is expected to grow at a double-digit CAGR of 15.7% to reach $1,463.0 million by 2020 from $705.5 million in 2015 Major factors fueling market growth are the increase in adoption of protein drugs over non-protein drugs, high prevalence rate of lifestyle diseases, growth in funding for protein engineering, and reduction in overall timeline and cost for drug discovery. However, expensive and high maintenance tools and instruments used in protein engineering and dearth of trained personnel are restricting the growth of the market. This market is broadly segmented into instrument, reagent and services and software, by product. On the basis of technology the market is segmented into rational protein design, and irrational protein design. Rational protein design emerged as highly adopted technology in protein engineering market in 2014. Based on protein type, the market is categorized into monoclonal antibodies, insulin, erythropoietin, interferon, colony stimulating factor, growth hormones, coagulation factor, vaccines and others (interleukins, follicle stimulating hormones, enzyme replacement). Monoclonal antibodies is the largest as well as fastest growing segment of the protein engineering protein type market. Based on end user, the protein engineering market is broadly classified into academic research institutes, pharmaceutical and biotechnology companies and contract research organizations. Pharmaceutical and biotechnology companies is the largest and fastest-growing end user segment. The high growth rate of this market can be attributed to technological advancements in protein engineering and the increase in R&D budgets in the pharmaceutical sector. Geographically, this market is dominated by North America, followed by Europe. Asia is expected to be the fastest growing region during the forecast period. Key players operating in this market are AB-Sciex (U.S.), Agilent Technologies (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corp. (U.S.), , GE Healthcare (U.K.), Perkin Elmer (U.S.), Sigma-Aldrich Corp. (U.S.), Thermo Fisher Scientific (U.S.), and Waters Corp. (U.S). Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Protein Engineering Market, By Product 8 Protein Engineering Market, By Technology 9 Protein Engineering Market, By Protein Type 10 Protein Engineering Market, By End User 11 Geographic Analysis 12 Competitive Landscape 13 Company Profiles - Agilent Technologies, Inc - Bio-Rad Laboratories, Inc - Bruker Corporation - Danaher Corporation - General Electric - Genscripts Usa, Inc. - Perkinelmer, Inc - Sigma-Aldrich Corporation - Thermo Fisher Scientific - Waters Corporation For more information visit http://www.researchandmarkets.com/research/shqb75/protein
A: 42.71 (-0.18), SIAL: 138.92 (+0.17), DHR: 85.25 (+0.05), WAT: 124.08 (-0.08)
Global Cell Analysis Market Report 2015 - Forecast to 2020
M2 - Wed Apr 08, 6:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/v8px4d/cell_analysis) has announced the addition of the "Cell Analysis Global Market - Forecast To 2020" report to their offering. Cell analysis plays a major role in gene identification, protein identification, transcription analysis and epigenomics at cellular level. It proves to be an ultra-sensitive device to elucidate specific molecular processes and pathways and reveal the nature of cell heterogenecity. Hospitals, academic institutions, government bodies, as well as pharmaceutical and biotechnology firms are increasing their focus on application of cell analysis as a modern emerging tool in research, drug discovery and diagnosis. The cell analysis techniques global market is segmented into molecular approaches, image-based approaches and others. The molecular approaches include the PCR, NGS and Microfluidics, cell isolation & separation techniques performed at cells genomic level, where as the image-based approaches include microscopes, FISH, FRAP, tracking, high content screening (HCS), cytometry techniques etc. The cell analysis products market is mainly segmented into consumables and instruments. The consumables include reagents, assay plates and microplates where as the instrument segment comprises of microscopes, flow cytometers, spectrophotometer, quantitative polymerase chain reaction (QPCR), microfluidic devices, cell counters, high content screening (HCS) systems and cell microarrays. By application, the market is segmented into by processes, by feild and by therapeutics. By processes is segmented into Cellular processes, Signal transduction pathways, Circulating tumor cells, Single cell analysis, Epigentic target analysis, Subpopulation Characterization, Drug and candidate screening. By field is further segmented into forensic Science, therapeutics, cell imaging, biomarker research, genomic analysis, stem cell analysis, and diagnostics. By therapeutics is further segmented into cancer research, infectious disease diagnosis, genetic testing, immunology, others. By end-users, the market is segmented into Hospitals, Academic and Research Institutes, Contract Research Organizations (CROs), Pharmaceuticals and Biotechnology Companies, Cell Banks, Diagnostic Laboratories and others. By geography, the market is segmented into North America, Europe, Asia Pacific and Rest of World. North America holds the largest market share, followed by Europe and Asia. The APAC regions tend to be an emerging market with an opportunity for growth and are likely to be a destination of investment for new investors in the cell analysis market. Drug discovery services outsourcing and government funding for novel screening technologies has resulted in growth of Asian markets. The cell analysis market is expected to grow at a rate of 9.6% during the forecast period. The major factor influencing the growth is enhanced precision of cell imaging and analysis systems which in turn reduce time and cost of drug discovery process. In addition, the factors like increasing incidence of cancer, increasing government investments, funds and grants, availability of reagents and cell analysis instruments are driving the growth of the market. However, the major market restraints include high capital investments and shortage of skilled labour for high content screening procedure. The biggest opportunities for this market is the emerging APAC market, high content screening services provided by contract research organizations, automation in cancer research for its early diagnosis and reduction of cost in the cancer treatment. Key Topics Covered: 1 Executive Summary 2 Introduction 3 Market Analysis 4 Cell Analysis Global Market, Techniques 5 Global Cell Analysis Products Market 6 Global Cell Analysis Applications Market 7 Cell Analysis Global Market, By End-Users 8 Regional Market Analysis 9 Company Developments 10 Major Player Profiles - Agilent Technologies, Inc. - Beckton, Dickinson And Company - Danaher Corporation - GE Healthcare - Merck KGaA - Olympus Corpopration - Perkinelmer, Inc - Promega Corporation - Sigma-Aldrich Corporation - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/v8...l_analysis
A: 42.71 (-0.18), SIAL: 138.92 (+0.17), DHR: 85.25 (+0.05)
Electric Motors - Global Strategic Business Report 2015-2020: Growth in Automotive Production Bodes Well for the Market
M2 - Tue Mar 31, 6:04AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jndtng/electric_motors) has announced the addition of the "Electric Motors - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Electric Motors in US$ Million by the following Segments: Fractional HP, and Integral HP. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 466 companies including many key and niche players such as: - ABB Ltd. (Switzerland) - Baldor Electric Company (USA) - ACTOM (Pty) Ltd (South Africa) - Allied Motion Technologies, Inc. (USA) - Ametek Inc. (USA) - ARC Systems Inc. (USA) - Asmo Co., Ltd (Japan) - Bauer Gear Motor (Germany) - Brook Crompton (UK) - Crompton Greaves Ltd. (India) - Danaher Motion (USA) - Franklin Electric Co. Inc., (USA) - General Electric Company (USA) - Hitachi, Ltd. (Japan) - Hyosung Corporation (South Korea) - Johnson Electric Holdings Ltd. (Hong Kong) - Kirloskar Electric Company Ltd. (India) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. MARKET DYNAMICS, TRENDS & ISSUES 3. PRODUCT OVERVIEW 4. PRODUCT INNOVATIONS/INTRODUCTIONS 5. RECENT INDUSTRY ACTIVITY 6. FOCUS ON SELECT KEY PLAYERS 7. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 466 (including Divisions/Subsidiaries - 520) - The United States (98) - Canada (2) - Japan (24) - Europe (241) - - France (11) - - Germany (58) - - The United Kingdom (26) - - Italy (67) - - Spain (
- - Rest of Europe (71) - Asia-Pacific (Excluding Japan) (143) - Latin America (1) - Middle East (6) - Africa (5) For more information visit http://www.researchandmarkets.com/research/jn...ric_motors GE: 26.91 (+0.29), ABB: 21.85 (-0.22), AME: 52.35 (+0.28), FELE: 38.87 (+0.14), AMOT: 40.48 (+1.00), DHR: 85.25 (+0.05)
Global Blood Screening Market to 2019: Nucleic Acid Amplification Test, ELISA, Rapid Test, Chemiluminescence Immunoassay, Next Generation Sequencing, Western Blotting
M2 - Mon Mar 30, 7:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jbkxl3/blood_screening) has announced the addition of the "Blood Screening Market by Technology (Nucleic Acid Amplification Test, ELISA, Rapid Test, Chemiluminescence Immunoassay, Next Generation Sequencing, Western Blotting), Product (Instrument, Reagent) & End User (Blood Bank, Hospital) - Forecasts to 2019 " report to their offering. The blood screening market is expected to reach $2.55 billion by 2019 from $1.5 billion in 2014, growing at a CAGR of 10.4% from 2014 to 2019. The global market is segmented on the basis of products and services, technologies, end users, and regions. The blood screening market is a growing field that has witnessed a number of technological advancements since its inception, such as a shift from first-generation ELISA to advanced NAT technologies. This market is driven by several factors including increasing number of blood donations and blood donors, rising awareness regarding the safety of donated blood, increasing patient affordability, increasing adoption of NAT, and rising demand of donated blood. However, factors such as high capital expenditure and operating cost of NAT and stringent regulatory approval processes are likely to hinder the growth of this market. The blood screening market in Asia is likely to provide an array of opportunities owing to the growing demand for donated blood, increasing disposable income (leading to adoption of NAT ), and increased focus of key players in the Asian region. On the basis of products and services, the global market is segmented into instruments (hardware), reagents, and software and services. The blood screening instruments market is further segmented into rental purchase and outright purchase; while the blood screening reagents market segment is classified into ELISA reagents, NAT reagents, and other reagents. On the basis of technologies, the global global market is segmented into nucleic acid tests (NAT), enzyme-linked immunosorbent assays (ELISA), enzyme immunoassays (EIAs) and chemiluminescent immunoassays (CLIAs), next-generation sequencing (NGS), and Western blot assays. The blood screening NAT market is further segmented into transcription mediated amplification (TMA) and real-time PCR. The blood screening market for ELISA testing is further categorized into card methodology, first-generation, second-generation, third-generation, and fourth-generation ELISA. Based on end users, the blood screening market is segmented into blood banks and hospitals. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Blood Screening Market, By Technology 8 Blood Screening Market, By Products and Services 9 Blood Screening Market, By End User 10 Blood Screening Market, By Region 11 Competitive Landscape 12 Company Profiles - Abbott Laboratories - Beckman Coulter (Subsidiary of Danaher Corporation) - Becton, Dickinson and Company - Bio-Rad Laboratories, Inc. - Biom?rieux - Grifols - Ortho-Clinical Diagnostics, Inc. - Roche Diagnostics (A Division of F. Hoffmann-La Roche Ltd) - Siemens Healthcare (Subsidiary of Siemens AG) - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/jb..._screening
ABT: 48.35 (+1.23), DHR: 85.25 (+0.05)
Danaher Schedules First Quarter 2015 Earnings Conference Call
PR Newswire - Thu Mar 26, 3:00PM CDT
Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the first quarter 2015 on Thursday, April 23, 2015 beginning at 8:00 a.m. ET and lasting approximately 1 hour.
DHR: 85.25 (+0.05)
